162 related articles for article (PubMed ID: 11127976)
1. Detection of chromogranin A in human gastric adenocarcinomas using a sensitive immunohistochemical technique.
Qvigstad G; Sandvik AK; Brenna E; Aase S; Waldum HL
Histochem J; 2000 Sep; 32(9):551-6. PubMed ID: 11127976
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine differentiation in gastric adenocarcinomas associated with severe hypergastrinemia and/or pernicious anemia.
Qvigstad G; Qvigstad T; Westre B; Sandvik AK; Brenna E; Waldum HL
APMIS; 2002 Feb; 110(2):132-9. PubMed ID: 12064868
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine differentiation in carcinoma of the breast. Tyramide signal amplification discloses chromogranin A-positive tumour cells in more breast tumours than previously realized.
Bofin AM; Qvigstad G; Waldum C; Waldum HL
APMIS; 2002 Sep; 110(9):658-64. PubMed ID: 12529020
[TBL] [Abstract][Full Text] [Related]
4. Chromogranin-A expression in gastric and colon cancer tissues.
Park JG; Choe GY; Helman LJ; Gazdar AF; Yang HK; Kim JP; Park SH; Kim YI
Int J Cancer; 1992 May; 51(2):189-94. PubMed ID: 1349007
[TBL] [Abstract][Full Text] [Related]
5. The prevalence and clinical significance of chromogranin A and secretogranin II immunoreactivity in colorectal adenocarcinomas.
Ferrero S; Buffa R; Pruneri G; Siccardi AG; Pelagi M; Lee AK; Coggi G; Bosari S
Virchows Arch; 1995; 426(6):587-92. PubMed ID: 7655739
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine differentiation in gastric adenocarcinomas. An immunohistochemical study.
Blumenfeld W; Chandhoke DK; Sagerman P; Turi GK
Arch Pathol Lab Med; 1996 May; 120(5):478-81. PubMed ID: 8639052
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine tissue-specific transcription factor, BETA2/NeuroD, in gastric carcinomas: a comparison with chromogranin A and synaptophysin expressions.
Fujii A; Kamiakito T; Takayashiki N; Fujii T; Tanaka A
Pathol Res Pract; 2003; 199(8):513-9. PubMed ID: 14533935
[TBL] [Abstract][Full Text] [Related]
8. Clinical and histopathological tumour progression in ECL cell carcinoids ("ECLomas").
Qvigstad G; Falkmer S; Westre B; Waldum HL
APMIS; 1999 Dec; 107(12):1085-92. PubMed ID: 10660138
[TBL] [Abstract][Full Text] [Related]
9. Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy.
Shia J; Tickoo SK; Guillem JG; Qin J; Nissan A; Hoos A; Stojadinovic A; Ruo L; Wong WD; Paty PB; Weiser MR; Minsky BD; Klimstra DS
Am J Surg Pathol; 2002 Jul; 26(7):863-72. PubMed ID: 12131153
[TBL] [Abstract][Full Text] [Related]
10. Metastatic conventional prostatic adenocarcinoma with diffuse chromogranin A and androgen receptor positivity.
Roudier MP; True LD; Vessella RL; Higano CS
J Clin Pathol; 2004 Mar; 57(3):321-3. PubMed ID: 14990610
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine cells in pancreatic duct adenocarcinoma: an immunohistochemical study.
Linder S; Myrvold K; Falkmer UG; Qvigstad G; Waldum HL; Falkmer SE
J Exp Clin Cancer Res; 2006 Jun; 25(2):213-21. PubMed ID: 16918133
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine differentiation in bronchial carcinomas of classic squamous-cell type: an immunohistochemical study of 29 cases applying the tyramide signal amplification technique.
Fresvig A; Qvigstad G; Halvorsen TB; Falkmer S; Waldum HL
Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):9-13. PubMed ID: 11277422
[TBL] [Abstract][Full Text] [Related]
13. Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells.
Ohike N; Jürgensen A; Pipeleers-Marichal M; Klöppel G
Virchows Arch; 2003 Mar; 442(3):258-65. PubMed ID: 12647216
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin type 2A receptor immunoreactivity in human pancreatic adenocarcinomas.
Pilichowska M; Kimura N; Schindler M; Kobari M
Endocr Pathol; 2001; 12(2):147-55. PubMed ID: 11579680
[TBL] [Abstract][Full Text] [Related]
15. Primary carcinoid tumor of the prostate with concurrent adenocarcinoma: a case report.
Ghannoum JE; DeLellis RA; Shin SJ
Int J Surg Pathol; 2004 Apr; 12(2):167-70. PubMed ID: 15173926
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract.
Fahrenkamp AG; Wibbeke C; Winde G; Ofner D; Böcker W; Fischer-Colbrie R; Schmid KW
Virchows Arch; 1995; 426(4):361-7. PubMed ID: 7599788
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine differentiation in gastric adenocarcinomas; correlation with tumor stage and expression of VEGF and p53.
Eren F; Celikel C; Güllüoğlu B
Pathol Oncol Res; 2004; 10(1):47-51. PubMed ID: 15029262
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of cluster 1 small cell lung cancer antigen and chromogranin A in lung carcinomas.
Noguchi M; Hirohashi S; Shimosato Y
Jpn J Clin Oncol; 1992 Feb; 22(1):6-9. PubMed ID: 1315401
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of elevated serum chromogranin A levels.
Syversen U; Ramstad H; Gamme K; Qvigstad G; Falkmer S; Waldum HL
Scand J Gastroenterol; 2004 Oct; 39(10):969-73. PubMed ID: 15513336
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of the proliferative activity of neuroendocrine tumors from various organs. Are there indications for a neuroendocrine tumor-carcinoma sequence?
Helpap B; Köllermann J
Virchows Arch; 2001 Jan; 438(1):86-91. PubMed ID: 11213840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
